Finally, a number of studies have considered the utility of combined biomarkers, such as CRP with interleukin-6 (Il-6) in periprosthetic joint pathology showing superiority over other biomarkers (including procalcitonin) when distinguishing between aseptic joint loosening and infection [35•, 36]. The gene discussed is CRP; the disease is infection.